Tardive Dyskinesia Awareness Week

Almost seven million people in the U.S. take antipsychotic medications for a wide range of ailments from schizophrenia to insomnia. Tragically, an estimated 600,000 U.S. citizens have developed a movement disorder called tardive dyskinesia because they took an antipsychotic, anti-nausea drug, or other prescription medicine that acts similarly in the brain. TD is often permanent and can dramatically impact daily activities, career pursuits, personal relationships and hobbies.  TD can dramatically affect quality of life: It “moderately or extremely affects” the following areas according to a 2021 poll*

➢ Ability to work (46%)
➢ Ability to sleep (53%)
➢ Ability to eat and drink (35%)

Almost half of people with TD experience moderate to severe anxiety or depression.** When untreated, TD can cause people to feel self-conscious and can even affect employment and social opportunities.

People taking first-generation or second- generation antipsychotics are at risk of developing TD.*** Those over 50 taking these medicines are in a high-risk population.

Nothing has been found to cure TD, but two FDA-approved medications may lessen the severity of TD symptoms. All patients should have access to appropriate diagnosis and treatment options.  Learn more with fact sheets, background, resources and FAQ.

*Patient ATU 2021. Target patients (n=350). Responses based on survey question: Since first experiencing involuntary movements, how has your ability to perform the following daily activities been affected, if at all?
**Published Commentary from Psychiatric Times. 2019. https://www.psychiatrictimes.com/view/tardive-dyskinesia-facts-and- figures. Accessed: February 4, 2022
***Dolder CR, Jeste DV. Incidence of tardive dyskinesia with typical versus atypical antipsychotics in very high-risk patients. Biol Psychiatry
2003; 53:1142-1145.